Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:30 March,2020
COVID-19 linked to cardiac injury even in patients without heart conditions: Study
Houston: COVID-19 can cause cardiac injury even in patients without underlying heart conditions, and have fatal consequences for people with cardiovascular disease, according to a review of studies. Experts have known that viral illnesses such as COVID-19 can cause respiratory infections that may lead to lung damage and even death in severe cases.
Caring for TB patients in the time of Coronavirus disease
India continues to have the highest burden of both TB and drug-resistant TB in the world. India launched a TB Free India Campaign on March 13, 2018 at the Delhi End TB Summit and has set 2025 as the deadline of eliminating TB from the country.
COVID-19 has given the answer for winter life-threatening pollution: Lock Down
COVID-19 pandemic has shown a scary picture in a number of countries and as a preventive measure, entire India has been locked down for 21 days starting from 25-03-2020.
Why do we Burn Camphor in any Pooja?
No Aarti is performed without camphor. Camphor, when lit, burns itself out completely without leaving a trace of it.
Health Sutras By Dr K K Aggarwal
Take vitamin D through sunlight 80 days in a year.
Healthcare News Monitor
Business Today- PB Jayakumar
While the whole world is battling a pandemic of unprecedented proportions, 43 pharmaceutical and biotech companies worldwide have launched their biggest ever research and development initiative to find the vaccine that can contain the novel coronavirus. Among these pharmaceutical majors are India's Zydus Cadila and Serum Institute. Experts believe it will take 12 to 18 months before a vaccine is available. Normally, a vaccine candidate, after clearing pre-clinical trials with small and large animals, have to go through three phases of clinical or human trials to prove its safety and efficacy. These human trials are done on different popuations in varied geographies and have to create huge data during their 3 phases for regulatory sanctions. In emergencies, like the coronavirus outbreak, fast-tracking is possible, but the vaccine candidate still have to go through various trials before being launched in open market. Typically, only one in ten experimental vaccines make it all the way through to regulatory approval. Therefore, different approaches mean the chances of success are higher. At present only one vaccine has entered the human trials stage and about 8-10 are nearing that milestone. The rest are still in pre-clinical stage.
Financial Express- Sarthak Ray
On Sunday, there were 677,938 cases of SARS CoV-2 infections around the globe and 31,746 died of Covid 19. Nearly 3 billion people are under partial or full lockdown, with the most extensive ones being enforced in India, China, France, Italy, New Zealand, Poland, South Africa and the UK (where the Prime Minister tested positive on Friday). Without vaccines or a new cure, nations are relying on existing, approved drugs/vaccines for other diseases with mixed reports of efficacy. While India has cleared the use of anti-malarial chloroquine and hudroxychloroquine as a prophylactic for healthcare workers at the frontline of the fight against Covid-19, the US is testing the antimalarials, apart from remdesivir, Gilead’s Ebola antiviral that didn’t fire at the time. Favipiravir, a drug developed by a subsidiary of Japanese photo-film giant Fujifilm, was tried on 340 Covid-19 patients in China’s Wuhan and Shenzhen, and Chinese medical authorities claim that subjects had tested negative for the virus in a median of four days after being detected as positive, compared to the median of 11 days for those who had not received the drug. Many countries, including India, have included restricted use of the fixed combination antiretroviral used in treating HIV, lopinavir/ritonavir, even though Chinese scientists reported that a controlled trial involving 199 SARS CoV-2 positive subjects, divided into two groups, didn’tjj return any significant positives over the standard treatment protocol.
The Times of India- T Ramavarman
THRISSUR: An ayurveda doctor’s liquor ‘prescription’ for a patient has gone viral in the backdrop of the reported move of the state government to provide liquor to people based on the prescriptions of doctors. However, within hours, the doctor clarified that he had sent a picture of the ‘prescription’ on a lighter vein to a couple of friends and did not expect it to reach the public domain. Meanwhile, the Kerala Prohibition Council had filed a police complaint against the doctor. Dr M D Renjit, who runs the Anjaly Ayurvedic Wellness Centre at North Paravur, had prescribed his ‘patient’ Purushothaman (48) ‘M C VSOP Brandy’ to be taken in 60ml thrice in the evening with roasted peanut. Dr Renjit now says that he had sent the ‘jocular prescription’ in an old letter-pad to three or four friends on WhatsApp and added that the ‘patient’ was fictitious. He added that one of his friends might have forwarded the ‘prescription’ to others, thus making it viral. “I sincerely apologize for the mistake I had committed,” he said. Renjit said he has already written to the bodies like Ayurveda Medical Association of India (AMAI), clarifying his stance. He said that he was also planning to approach the police against those who had shared his ‘private message’ without his permission.
India Today- Manjeet Singh Negi
colonel-rank doctor has tested positive for Covid-19 at Army Command Hospital in West Bengal's Kolkata, sources in the Indian Army said on Sunday. The officer was in New Delhi recently. The officer has been put under quarantine and all precautions are being taken for his colleagues as well, sources said. A junior commissioned officer in the Indian Army also tested positive for coronavirus on Sunday. The Colonel-rank doctor is serving at the Command Hospital in Kolkata while the JCO is posted to an Army base in Dehradun. The sources said the Army has traced all those who have come in contact with the two persons and accordingly they were quarantined. Both the doctor and the JCO are understood to have visited an Army facility near the national capital earlier this month. The two patients are keeping good health, sources said.